A phase II study about the efficacy of an intervention of excercise therapy on the adjuvant chemotherapy for pancreatic cancer: Exercise-PC Study
Not Applicable
- Conditions
- Invasive ductal adenocarcinoma of pancreas
- Registration Number
- JPRN-UMIN000030124
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
The completion rate of S-1 therapy, which is the primary endpoint, was 93% , which exceeded the threshold completion rate of 53% (P < 0.001).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe drug hypersensitivity or drug allergy 2. Multiple primary cancers within 5 years. 3. Severe infection 4. With watery diarrhea 5. Interstitial pneumonia or pulmonary fibrosis 6. With uncontrollable pleural effusion or ascites 7. With uncontrollable diabetes mellitus 8. With severe heart failure, angina, hypertension, arrhythmia 9. Walking akinesia 10. With severe malnutrition 11. With severe neurological/psychological symptoms 12. Pregnant or lactating women or women with unknown or suspected pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method